Modern methods of hernia tension free treatment use very wide range of modern biomaterials. Most of them are used transabdominal. For the best and most convenient treatment of large hernias would be a mesh suitable for intraperitoneal use with low adhesion ability to internal organs. the aim of the study was to compare three types of intraperitoneal meshes. material and methods. The study compared three types of intraperitoneal meshes. Sub-chronic (14 days) and chronic (90 days) macro-and microscopic examination were performed on rats (n = 69). Properties of the polypropylene mesh (PLP), Dynamesh ® -iPoM and polypropylene covered with chitosan (PLP+chitosan) were evaluated and compared. Results. It has been shown that the test meshes differ slightly during the healing process. conclusion. The PLP+chitosan mesh had the best biocompatible features of them all.
Abdominal hernias affect close to 5% of population, with the most common cases being that of inguinal hernia (75-80%) and post-operative hernia (8-10%) (1) .
The only treatment for hernia is surgery, as it does not undergo spontaneous curing or reduction. The only exception to this rule is the umbilical hernia in small children, which usually heals by itself and is managed with compression dressings (2, 3) .
The hernia treatment methods are classified into tension and tension-free ones. The former use patient's own self tissues in the wall plasty, which nevertheless causes long-term post-operative pain, creates tension on the suture line and often results in an unsatisfactorily high rate of recurrence (4, 5, 6) . The latter employ a synthetic material, the use of which may however cause chronic inflammation and in consequence, at later stages, development of adhesions that may lead to chronic unspecific pain and, in rarer cases, to gastro-* Both authors contributed equally in work intestinal tract obstruction or occurrence of enterocutaneous fistula (7, 8) . In order to prevent the complications, different types of implants are being used, however, long-term results remain unsatisfactory (9, 10) .
Currently, the materials most commonly used in the manufacture of hernia meshes are polytetrafluoroethylene (PTFE) or polypropylene (PP), and more rarely -polyester combined with a non-visceral-adhesive layer made of oxidised regenerated cellulose (oRC), silicone or collagen (the Proceed, Parietex or Parietene meshes). The limitation in the use of the above meshes is their high price.
Reduction in the number of complication cases, improvement of treatment results and -of no small importance -lowering of the manufacture costs are the main aspects inducing further search for an ideal biomaterial.
The aim of this study was to investigate and compare the properties of three types of meshes used in hernia treatment: the standard ones (PP), polypropylene ones with one-sided layer of polyvinylidene fluoride -PVFD (Dynamesh®-IPoM), and PP ones with one-sided layer of chitosan. All the studied meshes were implanted intraperitoneally. The comparison of studied meshes was made by macroscopic means, with the evaluation of such parameters as strength and type of adhesion, vascularisation degree, number of enteric adhesions, and by microscopy assessing the number and type of inflammatory reactions and the composition of the tissue connecting the implant with the body. Based on the subchronic (14 day) and chronic (90 day) follow up, an attempt was made at evaluating the clinical usefulness of the used biomaterials.
MATERIAL AND METHoDS
The study was conducted on female Wistar rats weighting 250-350 g (n = 90). After forming the control group ("0"), the remaining animals were divided into three groups in respect of the implanted material used: group 1 -PP mesh, group 2 -Dynamesh ® -IPoM mesh, and group 3 -PP mesh with on-sided chitosan layer. At the same time, each group was split into two, depending on the follow-up period duration (14 days or 90 days). Ultimately, the group sizes were as follows: control -"0" = 21 (n0 14days = 10, n0 90days = 11), group 1 = 23 (n1 14days = 12, n1 90days = 11), group 2 = 24 (n2 14days = 11, n2 90days = 13), and group 3 = 22 (n3 14days = 12, n3 90days = 10). The differences in the size of individual groups stemmed from the death of some of the animals due to unstable reaction to anaesthesia with ketamine. Despite the above, the numbers in all groups equalled or exceeded the planned n = 10 (tab. 1).
The PP and Dynamesh®-IPoM meshes were obtained from Tricomed. The former are a part of the domestic production, while Dynamesh®-IPoM are manufactured by a German company FEG Textiltechnik mbH. The PP meshes layered with chitosan are a product of cooperation between Tricomed and the Institute of Biopolymers and Chemical Fibres in Łódź. All the provided meshes, delivered sterile, were cut to an exact the same size: a square of 2 x 2 cm. The obtained tissue samples post resection, in 4% formaldehyde, were provided to olympus SA seated in Łódź for fixing in paraffin and preparation of microscopic specimens. Histopathology was performed by the investigators.
Implantation was performed in the same manner for all types of meshes. After delivering anaesthesia in the form of administered intramuscular ketamine at a dose of 20 mg/kg bw and subcutaneous atropine at 0.05 mg/kg bw (needles No 5), the rats were placed on the operating table in a supine position. The limbs were fixed with a tape wider than the animal limb length in order not to prevent blood supply. once the animals were positioned on the table, the abdominal region of the skin was shaved and disinfected (Cutasept). The abdominal cavity was opened with a cut along the linea alba (midline cut). The organs were moved to the right (from the investigator perspective) with the use of appropriate blunt instruments (skin hooks and blunt curettes) in order to gain free access to the parietal peritoneum on the left-hand side. Flat mesh (with cut corners to reduce irritation at those sites) measuring 2 x 2 cm was inserted in such a manner that its whole surface was in contact with parietal peritoneum on the left-hand side. Next, with the use of four single absorbable sutures put on its corners (6/0 Ethicon), the mesh was fixed to the peritoneum in a manner preventing it from shifting or folding due to the adhesion development. Properties comparison of intraperitoneal hernia meshes in reconstruction of the abdominal wall
The abdominal cavity was closed in two layers, i.e. the peritoneum and linea alba with the use of single absorbable sutures (6/0 Ethicon) and the skin with single non-absorbable sutures (4/0 Prolene). After the disinfection of postoperative wound, the animals were placed individually in disinfected cages.
The opening and closing of the abdominal cavity in the control group was performed in the same manner. However, instead of the mesh implantation, the peritoneal cavity was accessed with the use of the same instruments as in the study groups.
During the postoperative period, rats were given the LSM feed and water.
The resection of study material was performed at two time points post surgery: after 14 days in 35 rats and after 90 days in 34 rats. After atropine and ketamine administration, the abdominal cavity was reopened. In the control group, this was done by a separate cut (after 14 days in 10 rats and after 90 days in 11 rats). This was aimed at the visualisation of the peritoneal cavity closure site and evaluation of any potential adhesions between the scar, the applied sutures and the internal organs. In the study groups, relaparotomy was performed along the scar line and the mesh together with a fragment of abdominal wall to which it was attached were resected. After macroscopic examination, the animals were given Thiopental at a lethal dose. During the macroscopic examination, there were evaluated the implant condition, the number of adhesions to intraperitoneal organs, the migration and vascularisation as well as implant integration degree. Data from available publications were used in the formulation of all study scales (11, 12) .
In the assessment of inflammation (defined as inflammatory infiltrations), a triple-grade numerical scale was used, in which "0" meant no inflammation, "1" -slight granulation with mild inflammation reaction, while "2" represented a state with clearly visible ulcers and suppurations.
Mesh migration was identified as its shift in relation to the applied sutures.
Implant vascularisation combined with the degree of adhesion to tissue was assessed according to the following scale:
"0" non-attached mesh with no coverage of visible blood vessels; "1" mesh partially attached with no visible blood vessels; "2" mesh fully attached and covered with visible blood; "2+" implant fully integrated and extensively covered with a clear vascular stem.
The combined degree of mesh adhesion was evaluated based on the Vandendael scale enabling direct comparison of obtained results with literature data (13). Each of the adhesion features (thickness, width, strength and number) was given a certain amount of points (tab. 2), which when aggregated determined the adhesion type (tab. 3). on this scale, one of the parameters is the number of adhesions, which was calculated numerically in the case of permanently integrated parts of the intestine with continuity maintained with the implant over a section exceeding 2 mm. In cases where the organ adhered at more than 2 mm in its longest part, each new 2 mm was calculated as an extra adhesion.
After the macroscopic examination, whole specimens were fixed in formaldehyde. In a pathomorphlogical laboratory, paraffin blocks were made out of each of them, which were next cut every 5 µm in the widest plane with the use of a microtome and stained with hematoxylin-eosin, in order to obtain microscopic preparations. The degree and quality of the adhesion formed between the implanted mesh and the visceral peritoneum were evaluated. The histopathological assessment included also: the presence of macrophages, lymphocytes, platelets and the developed fibre tissue. The tissue connecting the mesh with the peritoneal wall, being the final product of inflammation occurring at the implantation site, further referred to as adhesion, was determined as the sum of inflammatory reaction and the fibre tissue. The amount of granulation and fibrosis surrounding the mesh was expressed as a percentage of the surface of the whole assessed preparation. Granulation consisted of a specific amount of inflammatory infiltration and fibrosis, which was expressed in their mutual percentage ratio in relation to whole granulation surrounding the mesh. In order to determine the differences in the volume and composition of the tissue covering the implant on the peritoneal side, statistical analysis was performed. The distribution of obtained results was not normal, and the data were subject to cumulative transformation for the purposes of using parametric tests. Data after transformation did not deviate from normal distribution, as demonstrated by the Shapiro-Wilk test, and were analysed with the use of unpaired Student's t-test to determine the p value for studied differences (p < 0.05 indicated significant differences). The StatsDirect (version 2.7.8) software was employed in the analysis.
RESULTS
In the control group, there were no pathological changes observed either after 14 days or after 90 days, in the form of an inflammatory infiltration or adhesion between the scar and internal organs. The closure site along with the applied sutures was visible. No adhesions joining the internal organs with each other were seen either.
In the study groups, in the first postoperative period of 14 days, the types of implanted meshes did not differ significantly between each other. They all produced a similar, mild, inflammatory reaction and did not result in enteric adhesions. on the Vandendeal scale, the PP and PP+chitosan meshes demonstrated strong adhesion with the visceral peritoneum, while Dynamesh®-IPoM scored one point less. After 14 days, the PP meshes adhered to the tissue on over half of their surface, Dynamesh®-IPoM did so to a smaller extent, while PLP+chitosan to the smallest. After 14 days, the histological composition of the tissue connecting the mesh with the body was similar: fibrosis was the dominant process, accounting for ca. 73% of the surface of connective tissue covering the implant on the abdominal cavity side. This proportion changed in time. After 90 days, the least extensive inflammatory infiltrations surrounded the PP+chitosan meshes, while the most extensive -PP. The latter still exhibited the largest adhesion surface, while the former -the smallest. The number of enteric adhesions changed in time as well: PP and PP+chitosan started to cause isolated adhesions. In addition, after 90 days, Dynamesh®-IPoM exhibited the largest number of blood vessels formed de novo, covering the implant.
The summary of macro-and microscopic observations is presented in tab. 4 and 5 and fig. 1 .
The performed statistical analysis indicated that the volume of tissue covering the PP+chitosan implants on the peritoneal side decreased significantly in time (p=0.0012). The tissue composition did not change significantly between time points 14 days and 90 days of follow up (p = 0.9473). The volume of tissue covering the Dynamesh ® -iPoM implants decreased significantly in time (p=0.009), and in its composition the amount of inflammatory infiltration dropped significantly (p = 0.0103). The volume of tissue covering the PP implants decreases significantly in time (p = 0.0015), and in its composition the amount of inflammatory infiltration dropped significantly (p = 0.0163). The differences in the tissue volume between the study materials in time after 14 days were statistically significant only for PP+chitosan and PP (p = 0.019). After 90 days of follow up, the differences between the study materials were significant for PP+chitosan and PP (p = 0.0145). After 14 days post implantation, the differences in the tissue composition between the study materials were not statistically significant. After 90 days, the composition of tissue covering the PP+chitosan meshes differed significantly from that of the one covering PP meshes (p = 0.0313) and Dynamesh *Ze względu na obserwowany w grupie kontrolnej podczas oceny makroskopowej brak zrostów między blizną a narządami wewnętrz-nymi grupę tę wyłączono z oceny mikroskopowej / Due to the lack of adhesions between the scar and internal organs found in the control group in macroscopic evaluation, this group was not evaluated by microscopic means Fig. 1 . Implantation of polypropylene mesh
DISCUSSIoN
Modern methods of hernia treatment are based on the use of synthetic material replacing the insufficient musculofascial layer. The biggest problem are large abdominal hernias with a significant depletion of musculofascial elements, necessitating intraperitoneal patch insertion.
Polypropylene is currently the standard of care in hernia treatment (14) . After mesh implantation, it causes intensive growth of mesenchymal cells into the mesh holes. Fibrosis involves not only the mesh but also the surrounding tissues, which produces additional strengthening of the abdominal wall. Unfor-24 P. Ławniczak et al. tunately, the above properties render PP of no use for the treatment of hernias in which the polypropylene mesh would have to come into direct contact with internal organs. This is because fibrosis induces the development of adhesions with abdominal cavity organs, which may later result in many complications (among others: unspecific pain or, more rarely, obstruction of the gastrointestinal tract and/or or occurrence of enterocutaneous fistula).
Dynamesh®-IPoM is a monofilamentous polypropylene mesh covered with a layer of polyvinylidene fluoride (PVFD) (15) . This is a highly crystalline non-strengthened fluoride polymer, combining good mechanical, thermal and electric properties with excellent chemical resistance. Dynamesh® has found extensive use in the treatment of hernias in which the mesh is to be in direct contact with internal organs. PVFD results in a statistically sig- Chitosan is a biologically active cellular cellulose, with properties resembling those of human collagen fibres.
An important aspect of using synthetic materials is the change in their size post implantation. The conducted studies have demonstrated that, for instance, the surface of polypropylene meshes may after a year drop by 20%, and after several years by close to 40%. Isolated reports indicate also the potential stretching of meshes (17, 18) . However, some authors claim that the changes in the mesh size are not associated with the biomaterial properties but occur due to the chronic inflammation in the surrounding tissues caused by, for instance, implant contamination. At the same time, the known biodegradable materials may provide insufficient protection against hernia recurrence. These reports incline to further search for a biomaterial which, while providing adequate mechanical function in the early post-operative period, could in itself prompt the body to rebuild the natural structures in the area operated on and would be absorbed after certain time. It could prove particularly useful in the filling of tissue losses in organs, where the application of nondegradable synthetic materials is not possible.
Yet another flaw of the applied biomaterials is the shifting of meshes post implantation. However, according to the majority of authors, this is not a result of the type of used material but a consequence of the employed surgical methods. This is because mesh migration concerns mainly the cases where it has not been appropriately secured with sutures or where the used sutures have been of short support period, which results in their more rapid biodegradation in terms of the time needed for the formation of sufficient mesh adhesion to the surrounding tissues, and thus in the associated hernia recurrence (19, 20, 21) .
It is difficult to identify the material that could be recognised as clearly the best among the studied mesh types.
All three studied mesh types were characterised by good integration with the recipient's tissue. No clear implant dislocation was observed. No acute inflammation caused by the intraperitoneal implant presence was seen either. Most of the used materials exhibited adhered mesh on the peritoneal side, and some the intestinal loops, both for the small and the large intestine. At the same time, no enteric adhesions causing obstruction were observed.
The expensive Dynamesh®-IPoM meshes underwent the most marked vascularisation and did not result in enteric adhesion formation in the chronic follow-up period, while at the same time their healing time was the longest. As regards the volume of adhered mesh surface, they rated poorer than PP meshes, while in terms of the adhesion tissue composition they were superseded by PP+chitosan meshes. The PP meshes, used as a standard, during the subchronic follow up exhibited as good adhesion as the two newer variants. In the longer period, they still proved superior in view of their larger surface adhered to the tissue, which indicates they could be the most stable in terms of migration. The meshes covered with resorbable chitosan resulted in the smallest irritation of the recipient's tissue, as evidenced by the lowest rate of inflammatory reaction within the connective tissue. In a longer period, however, they caused enteric adhesion, although not to a larger degree than PP meshes. Thus, the PP meshes led to the development of the most extensive stabilising scar which is the main factor in recovering the stability of regenerated tissue continuity. The Dynamesh®-IPoM meshes resulted in the lowest number of enteric adhesions which are the cause of the most acute and dangerous complications of tension-free hernia treatment methods. The PP+chitosan meshes proved the least irritating for the surrounding tissues, causing the smallest inflammatory reaction, which guarantees the implant acceptance and the least extensive adhesion to internal organs, and thus the lowest percentage of complications.
CoNCLUSIoNS
The obtained results suggest that polypropylene meshes with one-sided layer of chitosan equal, in terms of quality and anti-adhesion p r o p e r t i e s , t h e g l o b a l l y r e c o g n i s e d Dynamesh®-IPoM mesh. In view of the above, we believe that the studied mesh manufactured domestically deserves further independent studies prior to being accepted for clinical evaluation.
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